Novavax Inc (NVAX.O) said on Thursday it could begin commercial manufacturing of a Covid-19 vaccine tailored for the Omicron coronavirus variant in January next year, while it tests whether or not its current vaccine works against the variant.
Laboratory data expected in the coming weeks will show whether antibodies from individuals who have previously received Novavax's Covid-19 shot can neutralize the variant, according to the company.
#Omicron #Novavax #OmicronVaccine #IndiaToday
Subscribe to India Today for NEW VIDEOS EVERY DAY and make sure to enable Push Notifications so you'll never miss a new video.
All you need to do is PRESS THE BELL ICON next to the Subscribe button!
India Today TV is India's leading English News Channel. India Today YouTube channel offers latest news videos on Politics, Business, Cricket, Bollywood, Lifestyle, Auto, Technology, Travel, Entertainment and a lot more.
Stay tuned for latest updates and in-depth analysis of news from India and around the world!
Follow us: Official website: [ Ссылка ]
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Telegram: [ Ссылка ]
